Literature DB >> 16328780

Solution structure of the X4 protein coded by the SARS related coronavirus reveals an immunoglobulin like fold and suggests a binding activity to integrin I domains.

Karen Hänel1, Thomas Stangler, Matthias Stoldt, Dieter Willbold.   

Abstract

The SARS related Coronavirus genome contains a variety of novel accessory genes. One of these, called ORF7a or ORF8, code for a protein, known as 7a, U122 or X4. We set out to determine the three-dimensional structure of the soluble ectodomain of this type-I transmembrane protein by nuclear magnetic resonance spectroscopy. The fold of the protein is the first member of a further variation of the immunoglobulin like beta-sandwich fold. Because X4 does not reveal significant sequence homologies to proteins in the data bases, we carried out a structure based similarity search for proteins with known function. High structural similarity to Dl domains of ICAM-1 and ICAM-2, and common features in amino acid sequence between X4 and ICAM-1, suggest X4 to possess binding activity for the alpha(L) integrin I domain of LFA-1. Further, based on this structure based prediction, potential functions of X4 in virus replication and pathogenesis are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16328780      PMCID: PMC7089389          DOI: 10.1007/s11373-005-9043-9

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  17 in total

1.  The 7a accessory protein of severe acute respiratory syndrome coronavirus acts as an RNA silencing suppressor.

Authors:  Sumona Karjee; Ankita Minhas; Vikas Sood; Sanket S Ponia; Akhil C Banerjea; Vincent T K Chow; Sunil K Mukherjee; Sunil K Lal
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

2.  The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles.

Authors:  Scott R Schaecher; Jason M Mackenzie; Andrew Pekosz
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.

Authors:  Yongjun Tan; Theresa Schneider; Matthew Leong; L Aravind; Dapeng Zhang
Journal:  mBio       Date:  2020-05-29       Impact factor: 7.867

Review 4.  The role of epithelial integrin receptors in recognition of pulmonary pathogens.

Authors:  Marina Ulanova; Sean Gravelle; Rebecca Barnes
Journal:  J Innate Immun       Date:  2008-06-25       Impact factor: 7.349

Review 5.  From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses.

Authors:  Rolf Hilgenfeld; Malik Peiris
Journal:  Antiviral Res       Date:  2013-09-06       Impact factor: 5.970

6.  Genomics functional analysis and drug screening of SARS-CoV-2.

Authors:  Long Chen; Li Zhong
Journal:  Genes Dis       Date:  2020-04-14

7.  Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2.

Authors:  Intikhab Alam; Allan A Kamau; Maxat Kulmanov; Łukasz Jaremko; Stefan T Arold; Arnab Pain; Takashi Gojobori; Carlos M Duarte
Journal:  Front Cell Infect Microbiol       Date:  2020-07-27       Impact factor: 5.293

8.  Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.

Authors:  Rajanish Giri; Taniya Bhardwaj; Meenakshi Shegane; Bhuvaneshwari R Gehi; Prateek Kumar; Kundlik Gadhave; Christopher J Oldfield; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2020-07-25       Impact factor: 9.261

Review 9.  Accessory proteins of SARS-CoV and other coronaviruses.

Authors:  Ding Xiang Liu; To Sing Fung; Kelvin Kian-Long Chong; Aditi Shukla; Rolf Hilgenfeld
Journal:  Antiviral Res       Date:  2014-07-01       Impact factor: 5.970

10.  Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis Mechanisms of SARS-Related Coronaviruses.

Authors:  Yongjun Tan; Theresa Schneider; Matthew Leong; L Aravind; Dapeng Zhang
Journal:  bioRxiv       Date:  2020-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.